["{\n\"step_by_step_thinking\": \"The patient has uncontrolled blood sugar level and does not want to take injectable drugs. The relevant documents suggest that controlling blood glucose levels is valuable and feasible. However, the documents do not explicitly mention which drug can be added to control blood sugar.\n\nLooking at the patient's history of pancreatitis, it seems like a more conservative approach might be taken. Considering the options, none of them are injectable drugs. Therefore, an oral medication that is not sulfonylureas (since the patient does not want injectable drugs) could be considered.\n\nCanagliflozin and Sitagliptin are both DPP-4 inhibitors, which do not stimulate insulin secretion directly but instead help regulate glucose levels by inhibiting the action of DPP-4. Pioglitazone is a thiazolidinedione that acts as an agonist at peroxisome proliferator-activated receptor gamma (PPAR-gamma). Liraglutide, on the other hand, is a glucagon-like peptide-1 receptor agonist.\n\nConsidering these options, Canagliflozin or Sitagliptin could be considered as oral medications that can help control blood sugar levels without being injectable drugs.\",\n\"answer_choice\": C"]